Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report

Here, we discuss the safety and management of adverse events associated with pembrolizumab plus axitinib combination therapy for metastatic renal cell carcinoma in patients on hemodialysis. A 76-year-old man was diagnosed with cT3aN0M0 renal cell carcinoma due to gross hematuria. Stereoscopic radiot...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsumata, Yuki, Kawasaki, Yoshihide, Tanaka, Kayu, Nakayama, Daisuke, Katayama, Hiromichi, Shimada, Shuichi, Satake, Yohei, Sato, Takuma, Kawamorita, Naoki, Yamashita, Shinichi, Sato, Testuya, Shoji, Kosuke, Mitsuzuka, Koji, Ito, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613611/
https://www.ncbi.nlm.nih.gov/pubmed/34899246
http://dx.doi.org/10.1159/000519855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613611/
https://www.ncbi.nlm.nih.gov/pubmed/34899246
http://dx.doi.org/10.1159/000519855

Ejemplares similares